SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
MetLife, Inc. (MET) trades at a trailing P/E of 14.6, forward P/E of 7.8. Trailing earnings yield is 6.83%, forward earnings yield 12.84%. PEG 0.08 (Peter Lynch undervalued ≤1.0). Graham Number is $70.52.
Criteria proven by this page:
- VALUE (80/100, Pass) — P/E is below market average (14.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.08); analyst target implies upside (+27.3%); earnings yield beats bond yields (6.83%).
- Forward P/E 7.8 (down from trailing 14.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.08 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 6.83% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 12.84% as earnings recover.
- Analyst consensus target $96.83 (+27.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 65/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
80/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MET
Valuation Multiples
P/E (TTM)14.6
Forward P/E7.8
PEG Ratio0.08
Forward PEG0.08
P/B Ratio1.74
P/S Ratio0.64
EV/EBITDA8.2
Per Share Data
EPS (TTM)$5.08
Forward EPS (Est.)$9.76
Book Value / Share$43.49
Revenue / Share$114.49
FCF / Share$27.23
Yields & Fair Value
Earnings Yield6.83%
Forward Earnings Yield12.84%
Dividend Yield3.05%
Graham Number$70.52
SharesGrow IV$116.55 (+53.3%)
Analyst Target$96.83 (+27.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
61.9 |
-0.77 |
0.78 |
0.87 |
3.50% |
| 2017 |
13.2 |
0.03 |
0.90 |
0.85 |
3.45% |
| 2018 |
7.7 |
0.24 |
0.75 |
0.58 |
4.62% |
| 2019 |
7.9 |
0.34 |
0.71 |
0.67 |
3.90% |
| 2020 |
7.8 |
-1.24 |
0.56 |
0.62 |
4.43% |
| 2021 |
7.5 |
0.22 |
0.76 |
0.81 |
3.57% |
| 2022 |
10.7 |
-0.61 |
1.89 |
0.83 |
3.16% |
| 2023 |
32.0 |
-0.45 |
1.68 |
0.74 |
3.50% |
| 2024 |
12.8 |
0.06 |
2.06 |
0.81 |
3.06% |
| 2025 |
15.5 |
-0.79 |
1.85 |
0.68 |
3.24% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.73 |
$60.73B |
$850M |
1.4% |
| 2017 |
$3.74 |
$62.31B |
$4.01B |
6.4% |
| 2018 |
$5.20 |
$67.94B |
$5.12B |
7.5% |
| 2019 |
$6.06 |
$69.62B |
$5.9B |
8.5% |
| 2020 |
$5.68 |
$67.84B |
$5.41B |
8% |
| 2021 |
$7.70 |
$63.65B |
$6.86B |
10.8% |
| 2022 |
$2.91 |
$67.82B |
$5.28B |
7.8% |
| 2023 |
$1.81 |
$66.41B |
$1.58B |
2.4% |
| 2024 |
$5.94 |
$69.9B |
$4.43B |
6.3% |
| 2025 |
$4.80 |
$77.08B |
$3.38B |
4.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$9.78 |
$9.52 – $10.21 |
$79.36B |
$77.8B – $80.17B |
11 |
| 2027 |
$10.93 |
$10.65 – $11.39 |
$82.96B |
$80.97B – $84.73B |
11 |
| 2028 |
$12.30 |
$10.55 – $13.56 |
$87.04B |
$86.91B – $87.17B |
5 |
| 2029 |
$12.85 |
$12.25 – $13.32 |
$92.26B |
$89.24B – $94.2B |
1 |
